Cervical screening during the COVID-19 pandemic: optimising recovery strategies

A Castanon, M Rebolj, EA Burger… - The Lancet Public …, 2021 - thelancet.com
Disruptions to cancer screening services have been experienced in most settings as a
consequence of the COVID-19 pandemic. Ideally, programmes would resolve backlogs by …

Eliminating cervical cancer: progress and challenges for high-income countries

JC Davies-Oliveira, MA Smith, S Grover, K Canfell… - Clinical Oncology, 2021 - Elsevier
Abstract In 2020, the World Health Organization launched a major initiative to eliminate
cervical cancer globally. The initiative is built around the three key pillars of human …

Attitude towards HPV vaccination and the intention to get vaccinated among female university students in health schools in Jordan

M Sallam, K Al-Mahzoum, H Eid, AM Assaf… - Vaccines, 2021 - mdpi.com
Cervical cancer is a leading cause of morbidity and mortality in women worldwide. The
availability of prophylactic vaccines for high-risk types of human papillomavirus (HPV) …

Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an …

MA Smith, EA Burger, A Castanon, IMCM de Kok… - Preventive …, 2021 - Elsevier
COVID-19 has disrupted cervical screening in several countries, due to a range of policy-,
health-service and participant-related factors. Using three well-established models of …

A national cross-sectional study on the influencing factors of low HPV vaccination coverage in mainland China

X Yin, M Zhang, F Wang, Y Huang, Y Niu… - Frontiers in Public …, 2023 - frontiersin.org
Background HPV vaccine can block the infection of high-risk human papillomavirus and is
an important measure to effectively reduce the incidence of cervical cancer and …

Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: A mathematical modeling evaluation of HPV vaccination strategies in the …

G Liu, NR Mugo, C Bayer, DW Rao, M Onono… - …, 2022 - thelancet.com
Background Cervical cancer incidence is high in Kenya due to HIV and limited access to
cancer prevention services. Human papillomavirus (HPV) has been shown to increase HIV …

Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis

K Prem, YH Choi, É Bénard, EA Burger, L Hadley… - BMC medicine, 2023 - Springer
Background To eliminate cervical cancer as a public health problem, the World Health
Organization had recommended routine vaccination of adolescent girls with two doses of the …

[PDF][PDF] HPVsim: An agent-based model of HPV transmission and cervical cancer

RM Stuart, JA Cohen, CC Kerr, P Mathur - PLOS Computational …, 2024 - medrxiv.org
In 2020, the WHO launched its first Global Strategy to Accelerate the Elimination of Cervical
Cancer, outlining an ambitious set of targets for countries to achieve over the next decade …

Risk factors for human papillomavirus infection and disease: A targeted literature summary

M Del Pino, A Vorsters, EA Joura… - Journal of Medical …, 2024 - Wiley Online Library
Adolescents are the primary cohort for routine human papillomavirus (HPV) vaccination, but
unvaccinated adults may also benefit. A lack of consensus on which adults to target and the …

Sociodemographic correlates of human papillomavirus vaccine uptake: opportunistic and catch-up vaccination in Norway

L Dong, M Nygård, BT Hansen - Cancers, 2021 - mdpi.com
Simple Summary HPV vaccination protects against virus that may cause cervical cancer.
Opportunistic HPV vaccination (ie, vaccination at a citizens' own initiative and cost) has been …